{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:03:22Z","timestamp":1788498202153,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.nbd.2021.105509","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T11:37:43Z","timestamp":1631792263000},"page":"105509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy"],"prefix":"10.1016","volume":"159","author":[{"given":"Jay J.","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Stefanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gawain","family":"McColl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"McAllum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105509_bb0005","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2021.105509_bb0010","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/brain\/awx044","article-title":"Insulin resistance and exendin-4 treatment for multiple system atrophy","volume":"140","author":"Bassil","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105509_bb0015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/abio.2001.5378","article-title":"A fluorescence-based one-step assay for serum non-transferrin-bound iron","volume":"299","author":"Breuer","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2021.105509_bb0020","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1074\/jbc.M409946200","article-title":"Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments","volume":"280","author":"Cole","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2021.105509_bb0025","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1021\/acs.inorgchem.7b00372","article-title":"Molecular aspects of a robust assay for ferroxidase function of ceruloplasmin","volume":"56","author":"Cortes","year":"2017","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.nbd.2021.105509_bb0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2021.105509_bb0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"Pt 4","key":"10.1016\/j.nbd.2021.105509_bb0040","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105509_bb0045","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105509_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/7854_2013_269","article-title":"Models of multiple system atrophy","volume":"22","author":"Fellner","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2021.105509_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/syn.21719","article-title":"Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy","volume":"68","author":"Fernagut","year":"2014","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2021.105509_bb0060","doi-asserted-by":"crossref","first-page":"1.13.1","DOI":"10.1002\/0471142301.ns0113s27","article-title":"Quantified assessment of terminal density and innervation","volume":"27","author":"Finkelstein","year":"2004","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.nbd.2021.105509_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acschemneuro.5b00253","article-title":"Clioquinol improves cognitive, motor function, and microanatomy of the alpha-synuclein hA53T transgenic mice","volume":"7","author":"Finkelstein","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2021.105509_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","article-title":"The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson\u2019s disease","volume":"5","author":"Finkelstein","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2021.105509_bb0075","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105509_bb0080","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1039\/C7MT00244K","article-title":"Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain","volume":"9","author":"Genoud","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.nbd.2021.105509_bb0085","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2021.105509_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies","volume":"251","author":"Grazia Spillantini","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2021.105509_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuint.2017.01.004","article-title":"Ferroptosis and cell death mechanisms in Parkinson\u2019s disease","volume":"104","author":"Guiney","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2021.105509_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2012.11.009","article-title":"Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy","volume":"325","author":"Han","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2021.105509_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnagi.2013.00034","article-title":"A delicate balance: iron metabolism and diseases of the brain","volume":"5","author":"Hare","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2021.105509_bb0110","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1039\/C3SC53461H","article-title":"An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta","volume":"5","author":"Hare","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.nbd.2021.105509_bb0115","doi-asserted-by":"crossref","first-page":"36410","DOI":"10.1038\/srep36410","article-title":"Significant glial alterations in response to iron loading in a novel organotypic hippocampal slice culture model","volume":"6","author":"Healy","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2021.105509_bb0120","article-title":"Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases","volume":"4","author":"Heidari","year":"2016","journal-title":"Rare Dis."},{"key":"10.1016\/j.nbd.2021.105509_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbrc.2009.11.080","article-title":"Converse modulation of toxic alpha-synuclein oligomers in living cells by N\u2019-benzylidene-benzohydrazide derivates and ferric iron","volume":"391","author":"Hillmer","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2021.105509_bb0130","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1039\/C5SC00233H","article-title":"Direct in vivo imaging of ferrous iron dyshomeostasis in ageing Caenorhabditis elegans","volume":"6","author":"James","year":"2015","journal-title":"Chem. Sci."},{"key":"10.1016\/j.nbd.2021.105509_bb0135","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1523\/JNEUROSCI.2922-06.2006","article-title":"Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice","volume":"26","author":"Jeong","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105509_bb0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2021.105509_bb0145","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3233\/JAD-170601","article-title":"The relevance of iron in the pathogenesis of multiple system atrophy: a viewpoint","volume":"61","author":"Kaindlstorfer","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2021.105509_bb0150","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1212\/WNL.0000000000005637","article-title":"Putaminal iron deposition precedes MSA-P onset by 2 years","volume":"90","author":"Kikuchi","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2021.105509_bb0155","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/mds.23192","article-title":"Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry","volume":"25","author":"Kollensperger","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105509_bb0160","first-page":"293","article-title":"Multiple system atrophy with a-\/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases","volume":"42","author":"Kurisaki","year":"2002","journal-title":"Rinsho Shinkeigaku"},{"issue":"8","key":"10.1016\/j.nbd.2021.105509_bb0165","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1007\/s00415-013-6951-x","article-title":"Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy","volume":"260","author":"Lee","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2021.105509_bb0170","first-page":"53737","article-title":"Standards for quantitative metalloproteomic analysis using size exclusion ICP-MS","author":"Lothian","year":"2016","journal-title":"J. Visualized Exp. JoVE"},{"key":"10.1016\/j.nbd.2021.105509_bb0175","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2021.105509_bb0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","article-title":"Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration","volume":"133","author":"Masaldan","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2021.105509_bb0185","doi-asserted-by":"crossref","first-page":"101744","DOI":"10.1016\/j.pneurobio.2019.101744","article-title":"Regional iron distribution and soluble ferroprotein profiles in the healthy human brain","volume":"186","author":"McAllum","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105509_bb0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4331\/wjbc.v5.i2.204","article-title":"Ceruloplasmin-ferroportin system of iron traffic in vertebrates","volume":"5","author":"Musci","year":"2014","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.nbd.2021.105509_bb0195","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10534-012-9523-0","article-title":"Iron toxicity in neurodegeneration","volume":"25","author":"N\u00fa\u00f1ez","year":"2012","journal-title":"Biometals"},{"key":"10.1016\/j.nbd.2021.105509_bb0200","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s12035-015-9146-x","article-title":"Alpha-synuclein over-expression induces increased iron accumulation and redistribution in iron-exposed neurons","volume":"53","author":"Ortega","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.nbd.2021.105509_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00401-017-1772-0","article-title":"Multiple system atrophy: experimental models and reality","volume":"135","author":"Overk","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2021.105509_bb0210","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105509_bb0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1385\/BTER:112:3:221","article-title":"Non-protein-bound iron detection in small samples of biological fluids and tissues","volume":"112","author":"Paffetti","year":"2006","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.nbd.2021.105509_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/117.2.235","article-title":"The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology","volume":"117","author":"Papp","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105509_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2021.105509_bb0230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jinorgbio.2009.11.005","article-title":"Binding of \u03b1-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes","volume":"104","author":"Peng","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.nbd.2021.105509_bb0235","doi-asserted-by":"crossref","first-page":"1606S","DOI":"10.3945\/ajcn.117.155887","article-title":"Laboratory methodologies for indicators of iron status: strengths, limitations, and analytical challenges","volume":"106","author":"Pfeiffer","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.nbd.2021.105509_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10072-016-2756-x","article-title":"Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment","volume":"38","author":"Poli","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2021.105509_bb0245","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3233\/JAD-200551","article-title":"The iron chelator deferiprone improves the phenotype in a mouse model of tauopathy","volume":"77","author":"Rao","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2021.105509_bb0250","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2012.05.009","article-title":"Ironing out cell death mechanisms","volume":"149","author":"Reed","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105509_bb0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","article-title":"Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies","volume":"6","author":"Refolo","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2021.105509_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12868-019-0507-7","article-title":"Iron concentrations in neurons and glial cells with estimates on ferritin concentrations","volume":"20","author":"Reinert","year":"2019","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2021.105509_bb0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10286-014-0266-6","article-title":"Animal models of multiple system atrophy","volume":"25","author":"Stefanova","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.nbd.2021.105509_bb0270","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","article-title":"Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy","volume":"166","author":"Stefanova","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2021.105509_bb0275","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial \u03b1-synucleinopathy: implications for multiple system atrophy","volume":"22","author":"Stefanova","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105509_bb0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-012-0977-5","article-title":"Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy","volume":"124","author":"Stefanova","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2021.105509_bb0285","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3174\/ajnr.A2765","article-title":"Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging","volume":"33","author":"Wang","year":"2012","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2021.105509_bb0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: a review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105509_bb0295","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21465","article-title":"Multiple system atrophy: a primary oligodendrogliopathy","volume":"64","author":"Wenning","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105509_bb0300","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1016\/S0021-9258(18)52966-5","article-title":"Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans cinnamon mutant rat","volume":"268","author":"Yamada","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2021.105509_bb0305","first-page":"398","article-title":"An autopsy case of multiple system atrophy with a heteroallelic ceruloplasmin gene mutation","volume":"43","author":"Yomono","year":"2003","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.nbd.2021.105509_bb0310","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000008091","article-title":"A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma","volume":"42","author":"Yonekawa","year":"1999","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.nbd.2021.105509_bb0315","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/glia.20416","article-title":"Cellular iron status influences the functional relationship between microglia and oligodendrocytes","volume":"54","author":"Zhang","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2021.105509_bb0320","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.10.006","article-title":"Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases","volume":"133","author":"Zheng","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2021.105509_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098072","article-title":"Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments","volume":"9","author":"Zumbrennen-Bullough","year":"2014","journal-title":"PLoS One"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121002588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121002588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:30:42Z","timestamp":1760851842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121002588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":65,"alternative-id":["S0969996121002588"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105509","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105509"}}